Speratum Biopharma, Inc.
Houston
About Speratum Biopharma, Inc.
Speratum Biopharma Inc. is a U.S.-based biopharmaceutical company formally founded in 2021, with corporate headquarters in Dover, Delaware, and R&D operations in San José, Costa Rica and Houston, Texas. We are dedicated to transforming the treatment of aggressive and resistant cancers through the development of next-generation RNA-based therapeutics. While our scientific foundation began in 2014 with pioneering research led by Dr. Christian Marín-Müller, it was in 2021 that Speratum Biopharma transitioned from an academic and incubator-led initiative into a commercially focused company. This milestone marked our incorporation in the United States, the establishment of structured corporate governance, and the launch of our clinical and translational development strategy.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: Less than $1M
- Total funding: $5.5M
- Funding stage: Seed
- Last round: Convertible Note (Nov 2024)
- Website: speratum.com
- Phone: +1 (346) 772-0300
Industries & Categories
Biotechnology, Health Care, Oncology, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/speratum-biopharma-inc-87436 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.